HA
NXTC icon

HHLR Advisors’s NextCure NXTC Stock Holding History

HHLR Advisors’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-46,992
Closed -$5.64M – 94
2021
Q1 		$5.64M Sell
46,992
-6,200
-12% -$898K 0.06% 73
2020
Q4 		$6.96M Hold
53,192
– – 0.06% 81
2020
Q3 		$5.62M Hold
53,192
– – 0.04% 76
2020
Q2 		$13.7M Sell
53,192
-34,606
-39% -$13.2M 0.13% 50
2020
Q1 		$39.1M Hold
87,798
– – 0.53% 29
2019
Q4 		$59.3M Hold
87,798
– – 0.74% 24
2019
Q3 		$32.5M Buy
87,798
+81,548
+1,305% +$26.5M 0.45% 32
2019
Q2 		$1.12M Buy
+6,250
New +$1.3M 0.03% 40

Other funds holding NXTC

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HHLR Advisors's NXTC Position: Q2 2021 in Review

HHLR Advisors sold out of NextCure (NXTC) in Q2 2021, closing a stake of 46,992 shares — an estimated $5.64M sold.

HHLR Advisors first reported a position in NXTC in Q2 2019 and held it in 8 quarters. The position peaked at $59.3M in Q4 2019. 78 funds tracked by Wall St. Rank hold NXTC as of Q2 2021.

  • HHLR Advisors reported no remaining NextCure position as of Q2 2021 after selling out during the quarter.
  • HHLR Advisors sold 46,992 NextCure shares in Q2 2021, an estimated $5.64M.
  • HHLR Advisors first reported a position in NextCure in Q2 2019 and held it in 8 quarters.
  • HHLR Advisors's NextCure position peaked at $59.3M in Q4 2019.
  • 78 funds tracked by Wall St. Rank held NextCure as of Q2 2021.

Based on HHLR Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.